- Home
- GIW vs RXST Comparison
GIW vs RXST Comparison
Compare GIW & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GIW | RXST |
|---|---|---|
| Founded | 2025 | 1997 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.1M | 366.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GIW | RXST |
|---|---|---|
| Price | $10.01 | $8.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.40 |
| AVG Volume (30 Days) | 158.8K | ★ 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $6.32 |
| 52 Week High | $10.05 | $31.79 |
Technical Indicators
Market Signals| Indicator | GIW | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 69.84 | 45.13 |
| Support Level | $9.96 | $7.65 |
| Resistance Level | $9.97 | $8.51 |
| Average True Range (ATR) | 0.02 | 0.54 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 100.00 | 52.37 |
Price Performance
Historical ComparisonAbout GIW GigCapital8 Corp. Class A Ordinary Shares
GigCapital8 Corp is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.